peptidesinstitute.org
HEALING

TB-500

TB-500 (Thymosin Beta-4 Synthetic)

Thymosin Beta-4 Analog for Healing and Recovery

Buy TB-500
— authoritative voices whose published research informed this article

The information on this page is compiled from peer-reviewed research and is provided for educational and research purposes only. It is not medical advice, a diagnosis, or a treatment recommendation. Peptides discussed here may not be approved for human use in your jurisdiction. Always consult a qualified healthcare provider before starting, stopping, or modifying any health protocol.

Overview

What is TB-500?

TB-500 is a synthetic version of Thymosin Beta-4 (TB4), a naturally occurring 43-amino acid peptide present in virtually all human and animal cells. Thymosin Beta-4 is one of the most abundant intracellular peptides and plays a central role in the protection, regeneration, and remodeling of injured or damaged tissues.

TB-500 promotes healing through several key mechanisms: upregulation of actin (a cell-building protein essential for tissue repair), promotion of cell migration to injury sites, reduction of inflammation, stimulation of new blood vessel growth (angiogenesis), and regulation of wound healing [1] processes. Its ability to promote cell migration is particularly significant, as it allows repair cells to travel through damaged tissue more efficiently.

TB-500 has shown efficacy in healing a wide range of injuries including muscle tears, tendon injuries, ligament sprains, skin wounds, and even cardiac tissue damage. It has been extensively used in veterinary medicine, particularly in equine sports medicine, for decades before gaining popularity in human biohacking and sports recovery communities.

TB-500 is often used in combination with BPC-157 for enhanced healing effects, as the two peptides work through complementary mechanisms.

Research Supply

Source high-purity TB-500 for your research

Buy TB-500
Protocol

Dosage Guide

Route: Subcutaneous or intramuscular injection

Dosing Schedule

PeriodDose
Loading phase2-2.5 mg twice weekly for 4-6 weeks
Maintenance2 mg once weekly for 4-6 weeks
Injury protocol2.5 mg twice weekly until healed

Reconstitution

VIAL SIZE5 mg
WATER VOLUME2 mL
CONCENTRATION2.5 mg/mL
Each 0.1 mL (10 units on a U-100 insulin syringe) = 0.25 mg

Injection Volumes

DoseVolumeSyringe Units
2.0 mg0.8 mL80 units
2.5 mg1.0 mL100 units

Cycling Protocol

ON PERIOD

4-6 weeks loading + 4-6 weeks maintenance

OFF PERIOD

2-4 weeks

Often stacked with BPC-157 for synergistic healing effects.

Administration Tips

  • TB-500 is systemically active, so injection site does not need to be near the injury
  • Subcutaneous injection in the abdomen is the most common method
  • Intramuscular injection near the injury site is also effective
  • Rotate injection sites
  • Store reconstituted solution refrigerated and use within 28 days
Safety

Risks & Side Effects

Commonly Reported

Injection site discomfort or rednessTemporary lethargy or tirednessHead rush or lightheadedness (shortly after injection)Mild nausea

Serious Risks

Allergic reactions

Swelling, rash, or difficulty breathing; discontinue immediately.

Theoretical cancer concern

TB-500 promotes angiogenesis and cell migration, which could theoretically support tumor growth in individuals with existing cancer. No direct evidence supports this concern, but caution is warranted.

Cardiovascular effects

Thymosin Beta-4 has been found in cardiac tissue and may affect heart function at very high doses.

Related Research

Related Peptides

Expert Voices

Experts Covering TB-500

Dr. William A. Seeds

MD -- Regenerative Medicine Pioneer

Dr. Andrew Huberman

PhD -- Stanford Neuroscientist

Jay Campbell

Health Optimization Author and Peptide Advocate

Dr. Ian W. Hamley

Diamond Professor of Physical Chemistry -- University of Reading

Matthew Farrahi

Biohacker, CEO of Sigma Compounds, and Fitness Creator

LEGAL DISCLAIMER

The information provided on this page is for educational and informational purposes only and is not intended as medical advice. TB-500 has not been approved by the FDA for any medical condition. Always consult with a qualified healthcare professional before starting any peptide therapy. Individual results may vary. Peptides Institute is not responsible for any adverse effects resulting from the use of information provided on this site.

Frequently Asked Questions

What is TB-500?
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring 43-amino acid peptide found in virtually all human cells. It plays a central role in tissue protection, regeneration, and remodeling. TB-500 has been used extensively in veterinary medicine for decades and is now studied in human research for injury recovery and systemic healing applications.
How does TB-500 work?
TB-500 promotes healing through several mechanisms: upregulating actin, a protein essential for cell structure and movement; stimulating cell migration to injury sites; promoting new blood vessel growth (angiogenesis); and reducing inflammation. Its ability to enhance cell migration is particularly notable, allowing repair cells to reach and work within damaged tissue more efficiently.
What injuries does TB-500 help with?
Animal and veterinary research documents TB-500's effects on muscle tears, tendon injuries, ligament sprains, skin wounds, and cardiac tissue damage. It has a long track record in equine sports medicine for musculoskeletal injuries. Human application extrapolates from this body of evidence, as no clinical trials in humans have been completed.
What is the TB-500 dosage?
Standard research protocols use a loading phase of 2 to 2.5 mg twice weekly for four to six weeks, followed by a maintenance phase of 2 mg once weekly for another four to six weeks. Injury-specific protocols often use 2.5 mg twice weekly until recovery. TB-500 is systemically active, so injection site does not need to be near the injury.
What are TB-500 side effects?
Reported side effects include injection site discomfort, temporary lethargy, lightheadedness shortly after injection, and mild nausea. More serious theoretical concerns include promotion of angiogenesis in those with existing cancer, and potential cardiovascular effects at very high doses. Allergic reactions are possible as with any injectable peptide.
TB-500 vs BPC-157: what is the difference?
TB-500 and BPC-157 are complementary healing peptides that work through different mechanisms. TB-500 operates primarily through actin regulation and cell migration; BPC-157 works through growth hormone receptor upregulation and nitric oxide pathways. They are frequently stacked together in recovery protocols because their mechanisms synergize for enhanced tissue repair.
How long does it take TB-500 to work?
Veterinary literature documents measurable healing improvements in horses within the first two to four weeks of a loading protocol. Anecdotal reports from human users describe reduced inflammation and improved recovery within one to three weeks. The timeline varies considerably based on injury severity, tissue type, dosage, and individual healing capacity.

References

  1. Malinda KM, Sidhu GS, Mani H, et al.. Thymosin beta4 accelerates wound healing [^1]. J Invest Dermatol. 1999. PMID 10469335
  2. Bock-Marquette I, Saxena A, White MD, et al.. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair [^2]. Nature. 2004. PMID 15565145
  3. Crockford D, Turjman N, Allan C, et al.. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci. 2010. PMID 20536467

Regulatory & Official Sources